SlideShare a Scribd company logo
PENETRATION
ENHANCERS
Naresh gorantla M.pharm, (Ph.D)
BALAJI COLLEGE OF PHARMACY,
ANANTAPUR
4/24/2020 1
 The aim of drug administration via skin can be either
the local therapy or the transdermal drug delivery of
the systemic circulation.
 Transdermal system delivers medications through the
skin direct into the blood stream.
 One long standing approach to increase the range of
drugs that can effectively delivered via this route has
been to use penetration enhancers: chemicals that
interact with skin constituents to promote drug flux.
4/24/2020PENETRATION ENHANCERS 2
4/24/2020PENETRATION ENHANCERS 3
A diagrammatical cross-section through human
skin
 Weight of skin: 8 pounds
 Surface Area: 20,000 sq. cm.
 Three layers:
 Epidermis (Stratum corneum):dead keratinized
cells, density 1.55,
palms& soles : 100 micrometer.
Other portions: 10 micrometer in dry state & 40 to
50 micrometer in hydrated state.
Dermis: consists of proteins in a matrix of muco
polysaccharide, blood vessels, lymphatics, nerves,
hair follicles, sebaceous & sweat glands.
Subcutaneous layer
4/24/2020PENETRATION ENHANCERS 4
 It involves passive diffusion of substance through skin.
 Transcorneal penetration:
 Intra cellular penetration.
 Inter cellular penetration.
 Transappendegeal Penetration.
4/24/2020PENETRATION ENHANCERS 5
 Solubility in stratum corneum
 Diffusion through stratum corneum
 Partitioning
 Diffusion through viable skin tissue
 Condition of skin
 Effect of moisture
 Effect of vehicles
 Effect of concentration of medicament
 Effect of surfactant
4/24/2020PENETRATION ENHANCERS 6
 Skin penetration enhancement technique have been
developed to improve bioavailability & increase the range of
drugs for which topical & transdermal delivery.
 Penetration enhancers penetrates through skin to decrease
the barrier resistance.
 Alternatively, physical mechanism such as iontophoresis &
phonophoresis can be used for certain cases of drugs.
4/24/2020PENETRATION ENHANCERS 7
 Chemical enhancers or penetration enhancers or absorption
promoters are the agents that interact with skin constituents
to promote the drug flux.
 Many agent have studied & evaluated for enhancement
properties.
 Yet their inclusion in skin formulation is limited due to
unknown mechanism & toxicity.
4/24/2020PENETRATION ENHANCERS 8
 Non toxic, non irritating, non allergic.
 Ideally work rapidly.
 Pharmacologically inert.
 Its duration of action should be predictable & reproducible.
 Should work unidirectionally.
 When removed from skin barrier properties should return
both rapidly & fully.
 Cosmetically acceptable.
 Compatible with both excipients & drug.
4/24/2020PENETRATION ENHANCERS 9
1. By increasing the diffusion coefficient of the drug.
2. By increasing the effective concentration of the drug in the
vehicle.
3. By improving partitioning between the formulation and the
stratum corneum.
4. By decreasing the skin thickness.
4/24/2020PENETRATION ENHANCERS 10
1. Surfactants :
a) Ionic: SLS, Na laureate, etc.
b) Non ionic : Tween 80, Polysorbates, etc.
2. Bile Salts & Derivatives :
E.g.. Na glyacolate, Na deoxycholate
3. Fatty Acid & Derivatives :
E.g.. Oleic acid, Caprylic acid, etc.
4. Chelating Agents :
E.g.. EDTA, Citric acid, etc.
4/24/2020PENETRATION ENHANCERS 11
5. Sulphoxide :
E.g.. DMSO, DMA, DMF, etc.
6. Polyols :
E.g. : PG, PEG, Glycerol, etc.
7. Monohydric Alcohols :
E.g. : Ethanol, 2- Propanol, etc.
8. Miscellaneous :
E.g. : a) Urea & its derivatives
b) Terpenes & Terpenoids
c) Phospholipids
d) Water
4/24/2020PENETRATION ENHANCERS 12
4/24/2020PENETRATION ENHANCERS 13
 The water content of human stratum corneum is
typically around 15-20% of tissue dry weight.
 Soaking the skin in water, exposing the membrane to
high humidities or, occluding allow the stratum
corneum to reach water contents in equilibrium with
underlying epidermal skin cells.
 Water content increases to 400%
 In general, increased tissue hydration appears to
increase transdermal delivery of both hydrophilic &
lipophilic permeants
4/24/2020PENETRATION ENHANCERS 14
 Water present in stratum corneum is in two form, bound
& free,
 Free form act as solvent for polar permeants to diffuse.
 MOA:
- free water act as solvent & alter solubility of permeants
& so its partitioning. .
- The corneocytes take up water and swell, such swelling
of cells would impact upon the lipid structure between
the corneocytes causing some disruption to the bilayer
packing.
4/24/2020PENETRATION ENHANCERS 15
 Dimethyl sulphoxide(DMSO), aprotic solvent which form
hydrogen bond with itself rather than with water.
 used in many areas of pharmaceutical sciences as a
‘‘universal solvent’’.
 Promotes both hydrophilic & hydrophobic permeants.
 Effect is concentration dependent(> 60% needed for
optimum action).
 At high concentration – erythema & whales, may
denature proteins.
 Metabolite dimethyl sulfide produces foul odor on
breath.
4/24/2020PENETRATION ENHANCERS 16
 To avoid above side effects researchers have
investigated chemically related materials – DMAC &
DMF
 MOA:
- denature protein, changes the keratin confirmation
from α - helical to β – sheet.
- interacts with the head groups of some bilayer
lipids to distort to the packing geometry.
- also may facilitate drug partitioning from formulation
to this universal solvent.
4/24/2020PENETRATION ENHANCERS 17
4/24/2020PENETRATION ENHANCERS 18
 First chemically design molecule as penetration enhancer.
 Promote flux both hydrophilic & lipophilic permeants.
 Highly lipophilic with Log o/w =6.2.
 Effective at low concentration(0.1 – 5%).
 Soluble in & compatible with most organic solvents.
 Enhances permeation of steroids, antiviral & antibiotics.
 MOA:
- Interact with the lipid domains of the stratum corneum.
- Partition into the lipid bilayer to disrupt their packing
arrangement.
 Mostly used member : 2- Pyrrolidone(2P) & N- Methyl -2-
Pyrrolidone(NMP).
 NMP & 2P are miscible with most organic solvents.
 Used for numerous molecules including hydrophilic (e.g.
mannitol, & 5-FU) and lipophilic ( hydrocortisone and
progesterone) permeants.
 Greater effect on hydrophilic drugs.
 MOA:
- may act by altering the solvent nature of the membrane and
pyrrolidones have been used to generate ‘reservoirs’ within
skin membranes.
- Such a reservoir effect offers potential for sustained release
of a permeant.
4/24/2020PENETRATION ENHANCERS 19
 Oleic acid & other long chain fatty acid are used.
 Effective at low concentration(<10%)
 Used both for hydrophilic & lipophilic drugs.
 Saturated alkyl chain lengths of around C10–C12 attached
to a polar head group yields a potent enhancer.
 In unsaturated compounds, the bent cis configuration is
expected to disturb intercellular lipid packing more than
trans.
 Used for estradiol, acyclovir, 5 FU, Salicylic acid.
 MOA:
- Interacts with & modifies the lipid domains of stratum
corneum discrete lipid domains is induced within stratum
corneum bilayer lipid on exposure to oleic acid.
4/24/2020PENETRATION ENHANCERS 20
 Ethanol is used most commonly in patches.
 Used for levonorgestrol, estrdiol, 5 FU, etc.
 Its effect is concentration dependent, at high
concentration causes dehydration of biological
membrane & decreases the permeation.
 Applied in concentration range from 1 – 10%.
 Branched alkanols lower activity
 1- Butanol most effective.
 1-octanol and 1-propranolol to be effective enhancers
for salicylic acid and nicotinamide.
4/24/2020PENETRATION ENHANCERS 21
 MOA:
- Act as solvent.
- alter solubility property of tissue leads to improvement in
drug partitioning.
- volatile nature of ethanol help in modifying thermodynamic
activity of drug.
- due to evaporation of ethanol drug concentration increases
providing supersaturated state with greater driving force
- Solvent drag may carry permeant into the tissue.
- As volatile solvent may extract lipid fraction from skin.
4/24/2020PENETRATION ENHANCERS 22
 Are made up of alkyl or aryl side chain with polar head
group.
 Have potential to damage human skin.
 Both anionic & cationic surfactant can be used, but non
ionic surfactant are safe.
 Non ionic – minor effect, anionic – pronounced effect.
 MOA:
- Solubalise the lipophilic active ingredient & also have
potential to solubalise lipids within the stratum corneum.
4/24/2020PENETRATION ENHANCERS 23
 Used as medicines, flavoring and fragrance agents.
 Hydrocarbon terpenes less potent, alcohol/ ketone
containing terpenes moderate and oxide & terpenoid
shows greatest enhancement .
 Smaller terpenes are more active than larger.
 Non polar(limonene) agents active for lipophilic drugs &
polar(menthol) for hydrophilic drugs.
 MOA:
- Modify the solvent nature of the stratum corneum,
improving drug partitioning.
- Alters thermodynamic activity of the permeant.
- Terpenes may also modify drug diffusivity through the
membrane.
4/24/2020PENETRATION ENHANCERS 24
 Hydrating agent, have been used in scaling conditions
such as psoriasis & other skin conditions.
 It produces significant stratum corneum hydration,
produces hydrophilic diffusion channels.
 Has keratolytic properties, usually when used in
combination with salicylic acid for keratolysis.
 Urea itself possesses only marginal penetration
enhancing activity.
 Cyclic urea analogues and found them to be as potent
as Azone for promoting indomethacin.
4/24/2020PENETRATION ENHANCERS 25
 Generally employed as vesicles (liposomes) to carry drugs.
 In a non-vesicular form as penetration enhancers.
 Phosphatidylcholine & hydrogenated soya bean
phospholipids have been reported to enhance penetration
of theophylline & diclofenac respectively.
 MOA:
- occlude the skin surface & thus increase tissue hydration.
- phospholipids fuse with stratum corneum lipids.
- this collapse of structure liberates permeant into the
vehicle where drug is poorly soluble and hence
thermodynamic activity could be raised so facilitating drug
4/24/2020
26
 It is difficult to select rationally a penetration enhancer
for a given permeant.
 Penetration enhancers tend to work well with co-
solvents such as PG or ethanol.
 Most penetration enhancers have a complex
concentration dependent effect.
 Permeation through animal skins & rodent skins are
generally considerably greater than those obtained with
human skin.
4/24/2020PENETRATION ENHANCERS 27
1. Act on the stratum corneum intracellular keratin,
denature it or modify its conformation.
2. Affect the desmosomes that maintain cohesion
between corneocytes.
3. Modify the intercellular lipid domains to reduce the
barrier resistance of the bilayer lipids.
4. Alter the solvent nature of the stratum corneum to
modify partitioning of the drug.
4/24/2020PENETRATION ENHANCERS 28
1. Modification of thermodynamic activity of the vehicle.
2. Solvent permeating through the membrane could
‘drag’ the permeant with it.
3. Solubalising the permeant in the donor, especially
where solubility is very low so that can reduce
depletion effects and prolong drug permeation.
4/24/2020PENETRATION ENHANCERS 29
4/24/2020PENETRATION ENHANCERS 30
4/24/2020PENETRATION ENHANCERS 31

More Related Content

What's hot

Nucleic acid based therapeutic drug delivery system
Nucleic acid based therapeutic  drug delivery systemNucleic acid based therapeutic  drug delivery system
Nucleic acid based therapeutic drug delivery system
tadisriteja9
 
Dissolution method and ivivc by ranjeet singh
Dissolution method and ivivc by ranjeet singhDissolution method and ivivc by ranjeet singh
Dissolution method and ivivc by ranjeet singh
Ranjeet Singh
 
Electrosomes preparation and application
Electrosomes preparation and applicationElectrosomes preparation and application
Electrosomes preparation and application
mahesh745
 
Liposomal gene delivery system
Liposomal gene delivery systemLiposomal gene delivery system
Liposomal gene delivery system
Durga Bhavani
 
Transport models biopharamaceutics
Transport models biopharamaceuticsTransport models biopharamaceutics
Transport models biopharamaceutics
SUJITHA MARY
 
Penetration enhancers Used in transdermal drug delivry
Penetration enhancers Used in transdermal drug delivryPenetration enhancers Used in transdermal drug delivry
Penetration enhancers Used in transdermal drug delivryMalLiKaRjunA yadav
 
Electrosome
Electrosome Electrosome
Electrosome
surya singh
 
Preparation and application of Niosomes
Preparation and application of  Niosomes Preparation and application of  Niosomes
Preparation and application of Niosomes
PV. Viji
 
Liposome preparation and evaluation
Liposome preparation and evaluationLiposome preparation and evaluation
Liposome preparation and evaluation
Mohammad Shadab Riyaz
 
Pharmacokinetics and pharmacodynamics of biotechnological products
Pharmacokinetics  and  pharmacodynamics  of  biotechnological  productsPharmacokinetics  and  pharmacodynamics  of  biotechnological  products
Pharmacokinetics and pharmacodynamics of biotechnological products
PV. Viji
 
Electrosome
ElectrosomeElectrosome
Electrosome
ajinkyadighe3
 
Microcapsules: types, preparation and evaluation
Microcapsules: types, preparation and evaluationMicrocapsules: types, preparation and evaluation
Microcapsules: types, preparation and evaluation
MOHAMMAD ASIM
 
Computers in Pharmaceutical emulsion development.
Computers in Pharmaceutical emulsion development. Computers in Pharmaceutical emulsion development.
Computers in Pharmaceutical emulsion development.
Arpitha Aarushi
 
Descriptive versus mechanistic modelling
Descriptive versus mechanistic modellingDescriptive versus mechanistic modelling
Descriptive versus mechanistic modelling
Sayeda Salma S.A.
 
Ethics of computing in pharmaceutical research
Ethics of computing in pharmaceutical researchEthics of computing in pharmaceutical research
Ethics of computing in pharmaceutical research
DRx Amit Chaudhari
 
Tumor targeting drug delivery
Tumor targeting drug deliveryTumor targeting drug delivery
Tumor targeting drug delivery
Manikant Prasad Shah
 
Computational modeling in drug disposition
Computational modeling in drug dispositionComputational modeling in drug disposition
Computational modeling in drug disposition
Himal Barakoti
 
in vitro dissolution and iviv correlation
 in vitro dissolution and iviv correlation  in vitro dissolution and iviv correlation
in vitro dissolution and iviv correlation
RoshanJain35
 
Self Micro Emulsifying Drug Delivery System
Self Micro Emulsifying Drug Delivery SystemSelf Micro Emulsifying Drug Delivery System
Self Micro Emulsifying Drug Delivery System
Sagar Savale
 
Biological process involved in drug targetting
Biological process involved  in drug targettingBiological process involved  in drug targetting
Biological process involved in drug targetting
Sayeda Salma S.A.
 

What's hot (20)

Nucleic acid based therapeutic drug delivery system
Nucleic acid based therapeutic  drug delivery systemNucleic acid based therapeutic  drug delivery system
Nucleic acid based therapeutic drug delivery system
 
Dissolution method and ivivc by ranjeet singh
Dissolution method and ivivc by ranjeet singhDissolution method and ivivc by ranjeet singh
Dissolution method and ivivc by ranjeet singh
 
Electrosomes preparation and application
Electrosomes preparation and applicationElectrosomes preparation and application
Electrosomes preparation and application
 
Liposomal gene delivery system
Liposomal gene delivery systemLiposomal gene delivery system
Liposomal gene delivery system
 
Transport models biopharamaceutics
Transport models biopharamaceuticsTransport models biopharamaceutics
Transport models biopharamaceutics
 
Penetration enhancers Used in transdermal drug delivry
Penetration enhancers Used in transdermal drug delivryPenetration enhancers Used in transdermal drug delivry
Penetration enhancers Used in transdermal drug delivry
 
Electrosome
Electrosome Electrosome
Electrosome
 
Preparation and application of Niosomes
Preparation and application of  Niosomes Preparation and application of  Niosomes
Preparation and application of Niosomes
 
Liposome preparation and evaluation
Liposome preparation and evaluationLiposome preparation and evaluation
Liposome preparation and evaluation
 
Pharmacokinetics and pharmacodynamics of biotechnological products
Pharmacokinetics  and  pharmacodynamics  of  biotechnological  productsPharmacokinetics  and  pharmacodynamics  of  biotechnological  products
Pharmacokinetics and pharmacodynamics of biotechnological products
 
Electrosome
ElectrosomeElectrosome
Electrosome
 
Microcapsules: types, preparation and evaluation
Microcapsules: types, preparation and evaluationMicrocapsules: types, preparation and evaluation
Microcapsules: types, preparation and evaluation
 
Computers in Pharmaceutical emulsion development.
Computers in Pharmaceutical emulsion development. Computers in Pharmaceutical emulsion development.
Computers in Pharmaceutical emulsion development.
 
Descriptive versus mechanistic modelling
Descriptive versus mechanistic modellingDescriptive versus mechanistic modelling
Descriptive versus mechanistic modelling
 
Ethics of computing in pharmaceutical research
Ethics of computing in pharmaceutical researchEthics of computing in pharmaceutical research
Ethics of computing in pharmaceutical research
 
Tumor targeting drug delivery
Tumor targeting drug deliveryTumor targeting drug delivery
Tumor targeting drug delivery
 
Computational modeling in drug disposition
Computational modeling in drug dispositionComputational modeling in drug disposition
Computational modeling in drug disposition
 
in vitro dissolution and iviv correlation
 in vitro dissolution and iviv correlation  in vitro dissolution and iviv correlation
in vitro dissolution and iviv correlation
 
Self Micro Emulsifying Drug Delivery System
Self Micro Emulsifying Drug Delivery SystemSelf Micro Emulsifying Drug Delivery System
Self Micro Emulsifying Drug Delivery System
 
Biological process involved in drug targetting
Biological process involved  in drug targettingBiological process involved  in drug targetting
Biological process involved in drug targetting
 

Similar to Penetration enhancers

Semisolids sb 2020
Semisolids sb 2020Semisolids sb 2020
Semisolids sb 2020
Mirza Salman Baig
 
permeation enhancers by Hemant Chalaune ist M pharm
permeation enhancers by  Hemant Chalaune ist  M pharm permeation enhancers by  Hemant Chalaune ist  M pharm
permeation enhancers by Hemant Chalaune ist M pharm
Gaule Jeevan
 
Transdermal drug delivery system
Transdermal drug  delivery system Transdermal drug  delivery system
Transdermal drug delivery system
ROHIT
 
Permeation enhancer of Transdermal drug delivery system
Permeation enhancer of Transdermal drug delivery systemPermeation enhancer of Transdermal drug delivery system
Permeation enhancer of Transdermal drug delivery system
chetanpatil2572000
 
Semisolid ppt
Semisolid pptSemisolid ppt
Semisolid ppt
Pooja Sadgir
 
Penetration Enhancers in Transdermal Drug Delivery System
Penetration Enhancers in Transdermal Drug Delivery SystemPenetration Enhancers in Transdermal Drug Delivery System
Penetration Enhancers in Transdermal Drug Delivery System
SimranDhiman12
 
Pharm D- semisolid chapter
Pharm D- semisolid chapterPharm D- semisolid chapter
Pharm D- semisolid chapter
Arshad Khan
 
Pharmaceutical Nanoparticles
Pharmaceutical Nanoparticles Pharmaceutical Nanoparticles
Pharmaceutical Nanoparticles
silambarasan I
 
self micro emulsifying drug delivery system
self micro emulsifying drug delivery systemself micro emulsifying drug delivery system
self micro emulsifying drug delivery system
Arpitha Aarushi
 
Semi solid as ndds
Semi solid as nddsSemi solid as ndds
Semi solid as ndds
vinsijuvin
 
Recent advances in formulation aspects & manufacturing of semisolids
Recent advances in formulation aspects & manufacturing of semisolidsRecent advances in formulation aspects & manufacturing of semisolids
Recent advances in formulation aspects & manufacturing of semisolids
Priyanka Modugu
 
Ethosome as novel drug delivery system (2)
Ethosome as novel drug delivery system (2)Ethosome as novel drug delivery system (2)
Ethosome as novel drug delivery system (2)
Ankit Sharma
 
Transdermal drug delivery systems
Transdermal drug delivery systemsTransdermal drug delivery systems
Transdermal drug delivery systems
KniTt-In Knitts
 
Formulation Development and In Vitro Evaluation of Microsponge Drug Delivery ...
Formulation Development and In Vitro Evaluation of Microsponge Drug Delivery ...Formulation Development and In Vitro Evaluation of Microsponge Drug Delivery ...
Formulation Development and In Vitro Evaluation of Microsponge Drug Delivery ...
YogeshIJTSRD
 
Semi solid dosage forms
Semi solid dosage forms Semi solid dosage forms
Semi solid dosage forms
Dr. Jigar Vyas
 
Emulgel ppt.
Emulgel ppt.Emulgel ppt.
Emulgel ppt.
sumeet sonaje
 
B.pharm- semisolid dosage form
B.pharm- semisolid dosage formB.pharm- semisolid dosage form
B.pharm- semisolid dosage form
Arshad Khan
 
A 2
A 2A 2
Transferosomes
Transferosomes Transferosomes
Transferosomes
GURUPRASAD S
 

Similar to Penetration enhancers (20)

Semisolids sb 2020
Semisolids sb 2020Semisolids sb 2020
Semisolids sb 2020
 
permeation enhancers by Hemant Chalaune ist M pharm
permeation enhancers by  Hemant Chalaune ist  M pharm permeation enhancers by  Hemant Chalaune ist  M pharm
permeation enhancers by Hemant Chalaune ist M pharm
 
Transdermal drug delivery system
Transdermal drug  delivery system Transdermal drug  delivery system
Transdermal drug delivery system
 
Permeation enhancer of Transdermal drug delivery system
Permeation enhancer of Transdermal drug delivery systemPermeation enhancer of Transdermal drug delivery system
Permeation enhancer of Transdermal drug delivery system
 
Semisolid ppt
Semisolid pptSemisolid ppt
Semisolid ppt
 
Penetration Enhancers in Transdermal Drug Delivery System
Penetration Enhancers in Transdermal Drug Delivery SystemPenetration Enhancers in Transdermal Drug Delivery System
Penetration Enhancers in Transdermal Drug Delivery System
 
Pharm D- semisolid chapter
Pharm D- semisolid chapterPharm D- semisolid chapter
Pharm D- semisolid chapter
 
Pharmaceutical Nanoparticles
Pharmaceutical Nanoparticles Pharmaceutical Nanoparticles
Pharmaceutical Nanoparticles
 
self micro emulsifying drug delivery system
self micro emulsifying drug delivery systemself micro emulsifying drug delivery system
self micro emulsifying drug delivery system
 
Semi solid as ndds
Semi solid as nddsSemi solid as ndds
Semi solid as ndds
 
Recent advances in formulation aspects & manufacturing of semisolids
Recent advances in formulation aspects & manufacturing of semisolidsRecent advances in formulation aspects & manufacturing of semisolids
Recent advances in formulation aspects & manufacturing of semisolids
 
Ethosome as novel drug delivery system (2)
Ethosome as novel drug delivery system (2)Ethosome as novel drug delivery system (2)
Ethosome as novel drug delivery system (2)
 
Transdermal drug delivery systems
Transdermal drug delivery systemsTransdermal drug delivery systems
Transdermal drug delivery systems
 
Ocular drug delivery
Ocular drug deliveryOcular drug delivery
Ocular drug delivery
 
Formulation Development and In Vitro Evaluation of Microsponge Drug Delivery ...
Formulation Development and In Vitro Evaluation of Microsponge Drug Delivery ...Formulation Development and In Vitro Evaluation of Microsponge Drug Delivery ...
Formulation Development and In Vitro Evaluation of Microsponge Drug Delivery ...
 
Semi solid dosage forms
Semi solid dosage forms Semi solid dosage forms
Semi solid dosage forms
 
Emulgel ppt.
Emulgel ppt.Emulgel ppt.
Emulgel ppt.
 
B.pharm- semisolid dosage form
B.pharm- semisolid dosage formB.pharm- semisolid dosage form
B.pharm- semisolid dosage form
 
A 2
A 2A 2
A 2
 
Transferosomes
Transferosomes Transferosomes
Transferosomes
 

More from Naresh Gorantla

Protein binding of drugs
Protein binding of drugsProtein binding of drugs
Protein binding of drugs
Naresh Gorantla
 
Drug distribution
Drug distributionDrug distribution
Drug distribution
Naresh Gorantla
 
Pharmaceutical packaging naresh
Pharmaceutical packaging nareshPharmaceutical packaging naresh
Pharmaceutical packaging naresh
Naresh Gorantla
 
Drug absorption naresh
Drug absorption   nareshDrug absorption   naresh
Drug absorption naresh
Naresh Gorantla
 
powders & granules
powders & granulespowders & granules
powders & granules
Naresh Gorantla
 
pharmaceutical incompatibilities_naresh
pharmaceutical incompatibilities_nareshpharmaceutical incompatibilities_naresh
pharmaceutical incompatibilities_naresh
Naresh Gorantla
 
Surgical Aids
Surgical AidsSurgical Aids
Surgical Aids
Naresh Gorantla
 
Extraction and galenicals
Extraction and galenicalsExtraction and galenicals
Extraction and galenicals
Naresh Gorantla
 
Semisolids
SemisolidsSemisolids
Semisolids
Naresh Gorantla
 
suppositories
suppositoriessuppositories
suppositories
Naresh Gorantla
 
2. emulsions and suspensions naresh
2. emulsions and suspensions   naresh2. emulsions and suspensions   naresh
2. emulsions and suspensions naresh
Naresh Gorantla
 
Bioavailability and bioequivalence
Bioavailability and bioequivalenceBioavailability and bioequivalence
Bioavailability and bioequivalence
Naresh Gorantla
 
Manufacturing of pharmaceutical dosage forms
Manufacturing of pharmaceutical dosage formsManufacturing of pharmaceutical dosage forms
Manufacturing of pharmaceutical dosage forms
Naresh Gorantla
 
Industrial hazards and safety
Industrial hazards and safetyIndustrial hazards and safety
Industrial hazards and safety
Naresh Gorantla
 
Family planning
Family planningFamily planning
Family planning
Naresh Gorantla
 
Herbomineral preparations
Herbomineral preparationsHerbomineral preparations
Herbomineral preparations
Naresh Gorantla
 
1. monophasic liquids naresh
1. monophasic liquids   naresh1. monophasic liquids   naresh
1. monophasic liquids naresh
Naresh Gorantla
 
Tablets
Tablets Tablets
Tablets
Naresh Gorantla
 
Capsules
CapsulesCapsules
Capsules
Naresh Gorantla
 
Parentrals
Parentrals Parentrals
Parentrals
Naresh Gorantla
 

More from Naresh Gorantla (20)

Protein binding of drugs
Protein binding of drugsProtein binding of drugs
Protein binding of drugs
 
Drug distribution
Drug distributionDrug distribution
Drug distribution
 
Pharmaceutical packaging naresh
Pharmaceutical packaging nareshPharmaceutical packaging naresh
Pharmaceutical packaging naresh
 
Drug absorption naresh
Drug absorption   nareshDrug absorption   naresh
Drug absorption naresh
 
powders & granules
powders & granulespowders & granules
powders & granules
 
pharmaceutical incompatibilities_naresh
pharmaceutical incompatibilities_nareshpharmaceutical incompatibilities_naresh
pharmaceutical incompatibilities_naresh
 
Surgical Aids
Surgical AidsSurgical Aids
Surgical Aids
 
Extraction and galenicals
Extraction and galenicalsExtraction and galenicals
Extraction and galenicals
 
Semisolids
SemisolidsSemisolids
Semisolids
 
suppositories
suppositoriessuppositories
suppositories
 
2. emulsions and suspensions naresh
2. emulsions and suspensions   naresh2. emulsions and suspensions   naresh
2. emulsions and suspensions naresh
 
Bioavailability and bioequivalence
Bioavailability and bioequivalenceBioavailability and bioequivalence
Bioavailability and bioequivalence
 
Manufacturing of pharmaceutical dosage forms
Manufacturing of pharmaceutical dosage formsManufacturing of pharmaceutical dosage forms
Manufacturing of pharmaceutical dosage forms
 
Industrial hazards and safety
Industrial hazards and safetyIndustrial hazards and safety
Industrial hazards and safety
 
Family planning
Family planningFamily planning
Family planning
 
Herbomineral preparations
Herbomineral preparationsHerbomineral preparations
Herbomineral preparations
 
1. monophasic liquids naresh
1. monophasic liquids   naresh1. monophasic liquids   naresh
1. monophasic liquids naresh
 
Tablets
Tablets Tablets
Tablets
 
Capsules
CapsulesCapsules
Capsules
 
Parentrals
Parentrals Parentrals
Parentrals
 

Recently uploaded

2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
Top five deadliest dog breeds in America
Top five deadliest dog breeds in AmericaTop five deadliest dog breeds in America
Top five deadliest dog breeds in America
Bisnar Chase Personal Injury Attorneys
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
thanhdowork
 
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
Ashish Kohli
 
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat  Leveraging AI for Diversity, Equity, and InclusionExecutive Directors Chat  Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
TechSoup
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
Digital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments UnitDigital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments Unit
chanes7
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
Group Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana BuscigliopptxGroup Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana Buscigliopptx
ArianaBusciglio
 
MATATAG CURRICULUM: ASSESSING THE READINESS OF ELEM. PUBLIC SCHOOL TEACHERS I...
MATATAG CURRICULUM: ASSESSING THE READINESS OF ELEM. PUBLIC SCHOOL TEACHERS I...MATATAG CURRICULUM: ASSESSING THE READINESS OF ELEM. PUBLIC SCHOOL TEACHERS I...
MATATAG CURRICULUM: ASSESSING THE READINESS OF ELEM. PUBLIC SCHOOL TEACHERS I...
NelTorrente
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)
Academy of Science of South Africa
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
Scholarhat
 
How to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold MethodHow to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold Method
Celine George
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxChapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 

Recently uploaded (20)

2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
Top five deadliest dog breeds in America
Top five deadliest dog breeds in AmericaTop five deadliest dog breeds in America
Top five deadliest dog breeds in America
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
 
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
 
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat  Leveraging AI for Diversity, Equity, and InclusionExecutive Directors Chat  Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
Digital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments UnitDigital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments Unit
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
Group Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana BuscigliopptxGroup Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana Buscigliopptx
 
MATATAG CURRICULUM: ASSESSING THE READINESS OF ELEM. PUBLIC SCHOOL TEACHERS I...
MATATAG CURRICULUM: ASSESSING THE READINESS OF ELEM. PUBLIC SCHOOL TEACHERS I...MATATAG CURRICULUM: ASSESSING THE READINESS OF ELEM. PUBLIC SCHOOL TEACHERS I...
MATATAG CURRICULUM: ASSESSING THE READINESS OF ELEM. PUBLIC SCHOOL TEACHERS I...
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
 
How to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold MethodHow to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold Method
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxChapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 

Penetration enhancers

  • 1. PENETRATION ENHANCERS Naresh gorantla M.pharm, (Ph.D) BALAJI COLLEGE OF PHARMACY, ANANTAPUR 4/24/2020 1
  • 2.  The aim of drug administration via skin can be either the local therapy or the transdermal drug delivery of the systemic circulation.  Transdermal system delivers medications through the skin direct into the blood stream.  One long standing approach to increase the range of drugs that can effectively delivered via this route has been to use penetration enhancers: chemicals that interact with skin constituents to promote drug flux. 4/24/2020PENETRATION ENHANCERS 2
  • 3. 4/24/2020PENETRATION ENHANCERS 3 A diagrammatical cross-section through human skin
  • 4.  Weight of skin: 8 pounds  Surface Area: 20,000 sq. cm.  Three layers:  Epidermis (Stratum corneum):dead keratinized cells, density 1.55, palms& soles : 100 micrometer. Other portions: 10 micrometer in dry state & 40 to 50 micrometer in hydrated state. Dermis: consists of proteins in a matrix of muco polysaccharide, blood vessels, lymphatics, nerves, hair follicles, sebaceous & sweat glands. Subcutaneous layer 4/24/2020PENETRATION ENHANCERS 4
  • 5.  It involves passive diffusion of substance through skin.  Transcorneal penetration:  Intra cellular penetration.  Inter cellular penetration.  Transappendegeal Penetration. 4/24/2020PENETRATION ENHANCERS 5
  • 6.  Solubility in stratum corneum  Diffusion through stratum corneum  Partitioning  Diffusion through viable skin tissue  Condition of skin  Effect of moisture  Effect of vehicles  Effect of concentration of medicament  Effect of surfactant 4/24/2020PENETRATION ENHANCERS 6
  • 7.  Skin penetration enhancement technique have been developed to improve bioavailability & increase the range of drugs for which topical & transdermal delivery.  Penetration enhancers penetrates through skin to decrease the barrier resistance.  Alternatively, physical mechanism such as iontophoresis & phonophoresis can be used for certain cases of drugs. 4/24/2020PENETRATION ENHANCERS 7
  • 8.  Chemical enhancers or penetration enhancers or absorption promoters are the agents that interact with skin constituents to promote the drug flux.  Many agent have studied & evaluated for enhancement properties.  Yet their inclusion in skin formulation is limited due to unknown mechanism & toxicity. 4/24/2020PENETRATION ENHANCERS 8
  • 9.  Non toxic, non irritating, non allergic.  Ideally work rapidly.  Pharmacologically inert.  Its duration of action should be predictable & reproducible.  Should work unidirectionally.  When removed from skin barrier properties should return both rapidly & fully.  Cosmetically acceptable.  Compatible with both excipients & drug. 4/24/2020PENETRATION ENHANCERS 9
  • 10. 1. By increasing the diffusion coefficient of the drug. 2. By increasing the effective concentration of the drug in the vehicle. 3. By improving partitioning between the formulation and the stratum corneum. 4. By decreasing the skin thickness. 4/24/2020PENETRATION ENHANCERS 10
  • 11. 1. Surfactants : a) Ionic: SLS, Na laureate, etc. b) Non ionic : Tween 80, Polysorbates, etc. 2. Bile Salts & Derivatives : E.g.. Na glyacolate, Na deoxycholate 3. Fatty Acid & Derivatives : E.g.. Oleic acid, Caprylic acid, etc. 4. Chelating Agents : E.g.. EDTA, Citric acid, etc. 4/24/2020PENETRATION ENHANCERS 11
  • 12. 5. Sulphoxide : E.g.. DMSO, DMA, DMF, etc. 6. Polyols : E.g. : PG, PEG, Glycerol, etc. 7. Monohydric Alcohols : E.g. : Ethanol, 2- Propanol, etc. 8. Miscellaneous : E.g. : a) Urea & its derivatives b) Terpenes & Terpenoids c) Phospholipids d) Water 4/24/2020PENETRATION ENHANCERS 12
  • 14.  The water content of human stratum corneum is typically around 15-20% of tissue dry weight.  Soaking the skin in water, exposing the membrane to high humidities or, occluding allow the stratum corneum to reach water contents in equilibrium with underlying epidermal skin cells.  Water content increases to 400%  In general, increased tissue hydration appears to increase transdermal delivery of both hydrophilic & lipophilic permeants 4/24/2020PENETRATION ENHANCERS 14
  • 15.  Water present in stratum corneum is in two form, bound & free,  Free form act as solvent for polar permeants to diffuse.  MOA: - free water act as solvent & alter solubility of permeants & so its partitioning. . - The corneocytes take up water and swell, such swelling of cells would impact upon the lipid structure between the corneocytes causing some disruption to the bilayer packing. 4/24/2020PENETRATION ENHANCERS 15
  • 16.  Dimethyl sulphoxide(DMSO), aprotic solvent which form hydrogen bond with itself rather than with water.  used in many areas of pharmaceutical sciences as a ‘‘universal solvent’’.  Promotes both hydrophilic & hydrophobic permeants.  Effect is concentration dependent(> 60% needed for optimum action).  At high concentration – erythema & whales, may denature proteins.  Metabolite dimethyl sulfide produces foul odor on breath. 4/24/2020PENETRATION ENHANCERS 16
  • 17.  To avoid above side effects researchers have investigated chemically related materials – DMAC & DMF  MOA: - denature protein, changes the keratin confirmation from α - helical to β – sheet. - interacts with the head groups of some bilayer lipids to distort to the packing geometry. - also may facilitate drug partitioning from formulation to this universal solvent. 4/24/2020PENETRATION ENHANCERS 17
  • 18. 4/24/2020PENETRATION ENHANCERS 18  First chemically design molecule as penetration enhancer.  Promote flux both hydrophilic & lipophilic permeants.  Highly lipophilic with Log o/w =6.2.  Effective at low concentration(0.1 – 5%).  Soluble in & compatible with most organic solvents.  Enhances permeation of steroids, antiviral & antibiotics.  MOA: - Interact with the lipid domains of the stratum corneum. - Partition into the lipid bilayer to disrupt their packing arrangement.
  • 19.  Mostly used member : 2- Pyrrolidone(2P) & N- Methyl -2- Pyrrolidone(NMP).  NMP & 2P are miscible with most organic solvents.  Used for numerous molecules including hydrophilic (e.g. mannitol, & 5-FU) and lipophilic ( hydrocortisone and progesterone) permeants.  Greater effect on hydrophilic drugs.  MOA: - may act by altering the solvent nature of the membrane and pyrrolidones have been used to generate ‘reservoirs’ within skin membranes. - Such a reservoir effect offers potential for sustained release of a permeant. 4/24/2020PENETRATION ENHANCERS 19
  • 20.  Oleic acid & other long chain fatty acid are used.  Effective at low concentration(<10%)  Used both for hydrophilic & lipophilic drugs.  Saturated alkyl chain lengths of around C10–C12 attached to a polar head group yields a potent enhancer.  In unsaturated compounds, the bent cis configuration is expected to disturb intercellular lipid packing more than trans.  Used for estradiol, acyclovir, 5 FU, Salicylic acid.  MOA: - Interacts with & modifies the lipid domains of stratum corneum discrete lipid domains is induced within stratum corneum bilayer lipid on exposure to oleic acid. 4/24/2020PENETRATION ENHANCERS 20
  • 21.  Ethanol is used most commonly in patches.  Used for levonorgestrol, estrdiol, 5 FU, etc.  Its effect is concentration dependent, at high concentration causes dehydration of biological membrane & decreases the permeation.  Applied in concentration range from 1 – 10%.  Branched alkanols lower activity  1- Butanol most effective.  1-octanol and 1-propranolol to be effective enhancers for salicylic acid and nicotinamide. 4/24/2020PENETRATION ENHANCERS 21
  • 22.  MOA: - Act as solvent. - alter solubility property of tissue leads to improvement in drug partitioning. - volatile nature of ethanol help in modifying thermodynamic activity of drug. - due to evaporation of ethanol drug concentration increases providing supersaturated state with greater driving force - Solvent drag may carry permeant into the tissue. - As volatile solvent may extract lipid fraction from skin. 4/24/2020PENETRATION ENHANCERS 22
  • 23.  Are made up of alkyl or aryl side chain with polar head group.  Have potential to damage human skin.  Both anionic & cationic surfactant can be used, but non ionic surfactant are safe.  Non ionic – minor effect, anionic – pronounced effect.  MOA: - Solubalise the lipophilic active ingredient & also have potential to solubalise lipids within the stratum corneum. 4/24/2020PENETRATION ENHANCERS 23
  • 24.  Used as medicines, flavoring and fragrance agents.  Hydrocarbon terpenes less potent, alcohol/ ketone containing terpenes moderate and oxide & terpenoid shows greatest enhancement .  Smaller terpenes are more active than larger.  Non polar(limonene) agents active for lipophilic drugs & polar(menthol) for hydrophilic drugs.  MOA: - Modify the solvent nature of the stratum corneum, improving drug partitioning. - Alters thermodynamic activity of the permeant. - Terpenes may also modify drug diffusivity through the membrane. 4/24/2020PENETRATION ENHANCERS 24
  • 25.  Hydrating agent, have been used in scaling conditions such as psoriasis & other skin conditions.  It produces significant stratum corneum hydration, produces hydrophilic diffusion channels.  Has keratolytic properties, usually when used in combination with salicylic acid for keratolysis.  Urea itself possesses only marginal penetration enhancing activity.  Cyclic urea analogues and found them to be as potent as Azone for promoting indomethacin. 4/24/2020PENETRATION ENHANCERS 25
  • 26.  Generally employed as vesicles (liposomes) to carry drugs.  In a non-vesicular form as penetration enhancers.  Phosphatidylcholine & hydrogenated soya bean phospholipids have been reported to enhance penetration of theophylline & diclofenac respectively.  MOA: - occlude the skin surface & thus increase tissue hydration. - phospholipids fuse with stratum corneum lipids. - this collapse of structure liberates permeant into the vehicle where drug is poorly soluble and hence thermodynamic activity could be raised so facilitating drug 4/24/2020 26
  • 27.  It is difficult to select rationally a penetration enhancer for a given permeant.  Penetration enhancers tend to work well with co- solvents such as PG or ethanol.  Most penetration enhancers have a complex concentration dependent effect.  Permeation through animal skins & rodent skins are generally considerably greater than those obtained with human skin. 4/24/2020PENETRATION ENHANCERS 27
  • 28. 1. Act on the stratum corneum intracellular keratin, denature it or modify its conformation. 2. Affect the desmosomes that maintain cohesion between corneocytes. 3. Modify the intercellular lipid domains to reduce the barrier resistance of the bilayer lipids. 4. Alter the solvent nature of the stratum corneum to modify partitioning of the drug. 4/24/2020PENETRATION ENHANCERS 28
  • 29. 1. Modification of thermodynamic activity of the vehicle. 2. Solvent permeating through the membrane could ‘drag’ the permeant with it. 3. Solubalising the permeant in the donor, especially where solubility is very low so that can reduce depletion effects and prolong drug permeation. 4/24/2020PENETRATION ENHANCERS 29